Heartflow, Inc. (HTFL)
$47.78-$0.32 (-0.67%) Today
Latest HTFL Insider Trades
John C.M. Farquhar - Officer
John C.M. Farquhar - OfficerJohn C.M. Farquhar - Officer
Campbell Rogers - OfficerJohn C.M. Farquhar - OfficerJohn C.M. Farquhar - OfficerCampbell Rogers - OfficerJohn C.M. Farquhar - OfficerJohn C.M. Farquhar - OfficerHeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 200,490 | $7.33M |
| Grant or award | 8 | 98,782 | |
| Option exercise | 28 | 424,402 | |
| Tax withholding / forfeiture | 8 | 12,601 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
68 Form 4 filings on record, the earliest from Aug 7, 2025, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Vikram Verghese - Officer | Grant or award | Common Stock | 21,052 | $0.00 | - | |
| Vikram Verghese - Officer | Other | Common Stock. | 9,516 | - | - | |
| Vikram Verghese - Officer | Grant or award | Stock Option | 110,629 | $0.00 | - | |
| Vikram Verghese - Officer | Other | Convertible Promissory Note | 9,516 | $0.00 | - | |
| Bain Capital Life Sciences Investors, LLC | Other | Common Stock | 12,014,234 | - | - | |
| Bain Capital Life Sciences Investors, LLC | Other | Common Stock | 433,924 | $15.20 | $6.60M | |
| Bain Capital Life Sciences Investors, LLC | Other | Series F Preferred Stock | 35,081,564 | $0.00 | - | |
| Bain Capital Life Sciences Investors, LLC | Other | Subordinated Convertible Promissory Note | 0 | $0.00 | - | |
| Casey M. Tansey - Director | Other | Common Stock | 3,072,759 | - | - | |
| Casey M. Tansey - Director | Other | Common Stock | 98,303 | - | - | |
| Casey M. Tansey - Director | Other | Common Stock | 16,447 | - | - | |
| Casey M. Tansey - Director | Other | Series B-1 Preferred Stock | 220,052 | - | - | |
| Casey M. Tansey - Director | Other | Series B-1 Preferred Stock | 330,078 | - | - | |
| Casey M. Tansey - Director | Other | Series B-1 Preferred Stock | 10,560 | - | - | |
| Casey M. Tansey - Director | Other | Series B-1 Preferred Stock | 7,040 | - | - | |
| Casey M. Tansey - Director | Other | Series B-2 Preferred Stock | 220,052 | - | - | |
| Casey M. Tansey - Director | Other | Series B-2 Preferred Stock | 330,078 | - | - | |
| Casey M. Tansey - Director | Other | Series B-2 Preferred Stock | 10,560 | - | - | |
| Casey M. Tansey - Director | Other | Series B-2 Preferred Stock | 7,040 | - | - | |
| Casey M. Tansey - Director | Other | Series C Preferred Stock | 665,623 | - | - | |
| Casey M. Tansey - Director | Other | Series C Preferred Stock | 21,295 | - | - | |
| Casey M. Tansey - Director | Other | Series D Preferred Stock | 10,106 | - | - | |
| Casey M. Tansey - Director | Other | Series D Preferred Stock | 80,855 | - | - | |
| Casey M. Tansey - Director | Other | Series D Preferred Stock | 323 | - | - | |
| Casey M. Tansey - Director | Other | Series D Preferred Stock | 2,586 | - | - | |
| Casey M. Tansey - Director | Other | Series F Preferred Stock | 1,164,179 | - | - | |
| Casey M. Tansey - Director | Other | Series F Preferred Stock | 37,244 | - | - | |
| Casey M. Tansey - Director | Other | Convertible Promissory Note | 51,736 | $0.00 | - | |
| Casey M. Tansey - Director | Other | Convertible Promissory Note | 1,655 | $0.00 | - | |
| Casey M. Tansey - Director | Other | Convertible Promissory Note | 16,447 | $0.00 | - | |
| Casey M. Tansey - Director | Grant or award | Stock Option | 47,420 | $0.00 | - | |
| Jeffrey C. Lightcap - Director | Other | Common Stock | 833,075 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Common Stock | 1,248,939 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Common Stock | 4,615,542 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series C Preferred Stock | 624,471 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series C Preferred Stock | 1,248,939 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series D Preferred Stock | 1,630,231 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series D Preferred Stock | 208,604 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series E Preferred Stock | 1,099,378 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series F Preferred Stock | 1,337,337 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Series F-1 Preferred Stock | 452,528 | - | - | |
| Jeffrey C. Lightcap - Director | Other | Convertible Promissory Note | 96,068 | $0.00 | - | |
| Jeffrey C. Lightcap - Director | Grant or award | Stock Option | 47,420 | $0.00 | - | |
| John C.M. Farquhar - Officer | Grant or award | Common Stock | 59,868 | $0.00 | - | |
| John C.M. Farquhar - Officer | Grant or award | Stock Option | 314,603 | $0.00 | - | |
| Campbell Rogers - Officer | Grant or award | Common Stock | 21,052 | $0.00 | - | |
| Campbell Rogers - Officer | Grant or award | Stock Options | 110,629 | $0.00 | - | |
 Julie A. Cullivan - Director | Grant or award | Stock Option | 23,710 | $0.00 | - | |
| Wayne Joseph Riley - Director | Grant or award | Stock Option | 23,710 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 68 HTFL filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Farquhar John C.M. | Officer, Director | 27,230 | $1.36M | View on EDGAR | |
| Farquhar John C.M. | Officer, Director | 32,676 | $1.47M | View on EDGAR | |
| Rogers Campbell | Officer | 9,219 | $380K | View on EDGAR |
Heartflow, Inc. (HTFL) had 27 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for HTFL runs to 68 Form 4 filings, the earliest from 2025-08-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of HTFL were filed in the last 90 days. 1 purchase is on record for this company.
9 insider sales of HTFL were filed in the last 90 days, totaling $7.33M.
This page tracks HTFL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add HTFL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
